Ackermans & Van Haaren NV (LON:0GYM)
216.40
+0.80 (0.37%)
At close: Nov 3, 2025
Ackermans & Van Haaren NV Revenue
Ackermans & Van Haaren NV had revenue of 3.03B EUR in the half year ending June 30, 2025, with 24.94% growth. This brings the company's revenue in the last twelve months to 6.19B, up 9.01% year-over-year. In the year 2024, Ackermans & Van Haaren NV had annual revenue of 6.04B with 15.74% growth.
Revenue (ttm)
6.19B EUR
Revenue Growth
+9.01%
P/S Ratio
1.17
Revenue / Employee
253.90K EUR
Employees
24,384
Market Cap
6.23B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.04B | 821.78M | 15.74% |
| Dec 31, 2023 | 5.22B | 820.13M | 18.63% |
| Dec 31, 2022 | 4.40B | 104.05M | 2.42% |
| Dec 31, 2021 | 4.30B | 387.12M | 9.90% |
| Dec 31, 2020 | 3.91B | -360.15M | -8.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 140.08B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |